Is Superior Weight Loss the Most Important Outcome in Bariatric Surgery?
Treatment of obesity is undergoing a major shift with the rapid adoption and dissemination of GLP-1 receptor agonists (GLP-1 RAs). These medications have demonstrated efficacy in promoting weight loss, in addition to their role in treatment of metabolic complications such as diabetes. Importantly, these favorable outcomes have led to discussion of the role of GLP-1 […]
Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists
This cohort study uses a large US insurance claims database to assess weight loss and ongoing costs associated with metabolic bariatric surgery vs glucagon-like peptide-1 receptor agonists.
GLP-1 Receptor Agonists for Intracranial Hypertension?
A meta-analysis strongly supports the use of GLP-1 and dual GIP/GLP-1 RAs for treatment of IIH.
STAT+: Why is Eli Lilly worth nearly $1 trillion?
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’ve got big FDA news to get into today — let’s get straight into it. FDA names Richard Pazdur as top drug regulator The FDA yesterday said it has chosen Richard Pazdur, its […]
Saxenda For Weight Loss: How Does It Work And Is It Safe?
Post Content
The Great GLP-1 Reset: Trump’s Medicare Deal Could Upend Telehealth’s Most Profitable Subscription
Trump’s GLP-1 price deal slashes costs and expands selective Medicare coverage—threatening telehealth startups and sparking a longevity-driven reset.
Medical Sciences, Vol. 13, Pages 265: Semaglutide from Bench to Bedside: The Experimental Journey Towards a Transformative Therapy for Diabetes, Obesity and Metabolic Liver Disorders
Medical Sciences, Vol. 13, Pages 265: Semaglutide from Bench to Bedside: The Experimental Journey Towards a Transformative Therapy for Diabetes, Obesity and Metabolic Liver Disorders Medical Sciences doi: 10.3390/medsci13040265 Authors: Ralf Weiskirchen Amedeo Lonardo Background/Objectives: Type 2 diabetes and obesity present escalating global health and economic challenges, highlighting the need for therapies that can effectively […]
As GLP-1 drugs go mainstream, this expert says health is more than a number on a scale
Popular weight-loss drugs known as GLP-1s could soon become more affordable for Americans. On Thursday, the Trump administration and two major drugmakers announced an agreement to drastically reduce the cost of the drugs for people enrolled in Medicare and Medicaid, as well as for cash buyers.
Wegovy and Ozempic tied to dramatically lower cancer deaths
GLP-1 drugs such as Ozempic and Wegovy may extend the lives of colon cancer patients, according to a major UC San Diego study. Patients on the medications had less than half the mortality rate of non-users. Researchers suspect the drugs’ anti-inflammatory and metabolic effects contribute to improved outcomes. They’re now calling for clinical trials to […]
Why Metsera’s Share Price Is Plummeting This Week
Key Points Metsera was the target of a bidding war by pharma giants. The company has an innovative obesity drug candidate. 10 stocks we like better than Metsera › Innovative biopharmaceutical company Metsera (NASDAQ: MTSR) has been climbing all year. It went public on Feb. 3 of this year, priced at $18 per share, and […]